NeoGenomics, Inc. Stock OTC Bulletin Board
Stocks
US64049M2098
Healthcare Facilities & Services
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 15/09 | NeoGenomics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 07:45 AM | |
| 28/08 | NeoGenomics Shares Rise After RaDaR ST Assay Gets Expanded Medicare Coverage | MT |
| Market Cap | 2.48B 2.18B 2.06B 1.88B 3.51B 238B 3.54B 24.63B 9.54B 122B 9.32B 9.12B 391B | P/E 2026 * |
-65.2x | P/E 2027 * | -77.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.48B 2.18B 2.06B 1.88B 3.51B 238B 3.54B 24.63B 9.54B 122B 9.32B 9.12B 391B | EV / Sales 2026 * |
3.09x | EV / Sales 2027 * | 2.81x |
| Free-Float |
96.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NeoGenomics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Anthony Zook
CEO | Chief Executive Officer | 65 | 01/04/2025 |
Abhishek Jain
DFI | Director of Finance/CFO | 57 | 02/03/2026 |
Warren Stone
PSD | President | 53 | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Lynn Tetrault
CHM | Chairman | 64 | 07/10/2021 |
Stephen Kanovsky
BRD | Director/Board Member | 63 | 19/07/2017 |
Michael Kelly
BRD | Director/Board Member | 69 | 15/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.92% | +11.69% | +153.15% | +817.41% | 59.47B | |
| +0.22% | -3.45% | +10.35% | +50.78% | 25.11B | |
| -0.63% | -2.34% | -11.16% | -38.35% | 6.52B | |
| -0.73% | -6.86% | -6.74% | +154.37% | 5.57B | |
| -0.46% | +2.92% | +22.23% | +61.31% | 3.4B | |
| -0.09% | -12.56% | -24.58% | +2,376.19% | 2.64B | |
| -1.18% | -2.91% | +143.76% | +57.03% | 2.48B | |
| +16.38% | +1.68% | +35.11% | +45.42% | 2.27B | |
| +1.10% | +4.93% | +0.79% | -53.43% | 2B | |
| Average | +1.73% | -0.64% | +35.88% | +385.64% | 12.16B | |
| Weighted average by Cap. | +0.79% | +4.90% | +88.67% | +521.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 804M 706M 666M 607M 1.14B 77.07B 1.14B 7.97B 3.09B 39.37B 3.02B 2.95B 127B | 885M 777M 733M 668M 1.25B 84.83B 1.26B 8.78B 3.4B 43.34B 3.32B 3.25B 139B |
| Net income | -39.05M -34.27M -32.37M -29.49M -55.21M -3.74B -55.61M -387M -150M -1.91B -147M -143M -6.15B | -32.73M -28.72M -27.12M -24.72M -46.27M -3.14B -46.6M -325M -126M -1.6B -123M -120M -5.15B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
